Medlife Pharmacy and Compounding

FDA inspection history in Irvine, California, 2018 to 2021

2
Close-outs
1
Form 483

Every document, by year

  • Close-out
  • Form 483

2018: one Form 483; 2020: one close-out letter; 2021: one close-out letter.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2018–21Two close-out letters and one Form 483, at Irvine, California.

Cited most

Across all Medlife Pharmacy and Compounding observations on file

The complete Medlife Pharmacy and Compounding file.

All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$297

The price of the documents, added to your cart together

Sites

Documents

3 on file, newest first
DateDocumentPrice
2021-11-29Close-out Close-out letter$99
2020-04-24Close-out Close-out letter$99
2018-04-18483 Form 483$99

Investigators on these documents

Yasamin Ameri (1)

FEI number 3014332926 · most recent document Nov 29, 2021

About Medlife Pharmacy and Compounding

How many FDA Form 483s has Medlife Pharmacy and Compounding received?

FDA Intel has 1 Form 483 on file for Medlife Pharmacy and Compounding; the most recent is dated Apr 18, 2018.

When was Medlife Pharmacy and Compounding last inspected by FDA?

The most recent FDA inspection document on file for Medlife Pharmacy and Compounding is a Form 483 dated Apr 18, 2018, for the site in Irvine, California.

What did FDA cite at Medlife Pharmacy and Compounding?

The regulations cited most in the observations on file for Medlife Pharmacy and Compounding are 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 1 time; 21 CFR 211.113 (Control of microbiological contamination), 1 time; 21 CFR 211.160 (General requirements), 1 time.